CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The DiogenX project aims to eliminate insulin dependency in type 1 diabetes by regenerating pancreatic beta cells. This approach seeks to restore the body's ability to release insulin autonomously in response to blood glucose levels, significantly improving patient quality of life.
Globally 8,75M people with T1D rely only on insulin administration to manage the symptoms of their disease.
The treatment is complex since it requires injecting insulin (2-4 times/day) and adhering to a restrictive lifestyle (e.g., following a strict diet) reducing patient QoL.
Even with insulin, less than 20% of patients achieve their target glucose level, which eventually leads to vascular complications (e.g., stroke, renal disease) reducing life expectancy by 10-15 years.
DiogenX aims to with…
DIOGENX SAS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
